Long Term Care Journal
Tuesday, March 22, 2016
FDA approves new psoriasis drug Taltz - FDA Press Releases
The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis.
from Food and Drug Administration--Press Releases http://ift.tt/1UiS9vF
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment